Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Depreciation & Amortization (CF) (2016 - 2026)

Angiodynamics' Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $5.6 million for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 11.52% year-over-year to $5.6 million; the TTM value through Feb 2026 reached $23.2 million, down 13.41%, while the annual FY2025 figure was $25.8 million, 6.9% down from the prior year.
  • Depreciation & Amortization (CF) reached $5.6 million in Q1 2026 per ANGO's latest filing, down from $5.7 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.8 million in Q1 2023 to a low of $5.6 million in Q1 2026.
  • Average Depreciation & Amortization (CF) over 5 years is $6.9 million, with a median of $6.8 million recorded in 2024.
  • Peak YoY movement for Depreciation & Amortization (CF): grew 17.52% in 2022, then dropped 16.26% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $7.8 million in 2022, then decreased by 14.49% to $6.7 million in 2023, then rose by 2.66% to $6.9 million in 2024, then decreased by 16.26% to $5.7 million in 2025, then decreased by 2.71% to $5.6 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Depreciation & Amortization (CF) are $5.6 million (Q1 2026), $5.7 million (Q4 2025), and $6.0 million (Q3 2025).